Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioCardia
Biotech
BioCardia rejigs phase 3 heart failure data to find a path
BioCardia’s data safety board already warned that the phase 3 CardiAMP cell therapy heart failure trial was not going to make the primary endpoint.
Annalee Armstrong
Mar 4, 2024 10:15am
BioCardia's cell therapy flunks phase 3 heart failure trial
Sep 5, 2023 9:35am
BioCardia off-the-shelf cell therapy to enter phase 1/2 study
Dec 6, 2022 11:19am
